Icon

Afinitor Disperz - (2,3,5 mg; Tablet For Suspension)

Everolimus Novartis
2,3,5 mg; Tablet For Suspension
More Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
None
None
Less Than 5
Used to treat adults and children with a genetic condition called tuberous sclerosis complex (TSC) who have a brain tumor called subependymal giant cell astrocytoma (SEGA)
Yes
***** ***** ** ** *** **** ** ****** **** ******** ** *** ****. ***** *** ********* **** ** **** ******* (*** *, ****), *******(*** **, ****) *** ******* (*** **, ****) ** ******* *** ** ********* ** ********. ***** **** *** ***** ************ ******* ******* *** *** *** ******* ** **** *** ***** ****** ****** *** ******* ******* ***-********** *****. ***** *** ** **** *** ******* ** ******** ** *******.
Afinitor Disperz Patent 1 Patent 2 Patent 3 Patent 4
***** ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** *** \ ********* *** *, **** ******* ******** ************ ******** ** *** **, ****
  1. *** **, **** : ***** ******** ******** ********* **** ** ******* ******* (*** *, ****), *******(*** **, ****) *** ******* (*** **, ****) ** *******.
  2. *** *, **** : ******** **** ***** ** ** ** ******** *** ******** ******** ** **** ********.
  3. *** **, **** : ***** **** *** ******* *******.
  4. *** **, **** : ********** **** ***** *********.
  5. *** *, **** : ***** ******** *** *******.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.